Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -25.45% is 85% above its 5-year average of -168.17%, near the high end of its 5-year range (-1132.21%–-25.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 50.19% above its 12-month average of -51.09%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -25.45%.
RETURN ON INVESTED CAPITAL (ROIC)
-25.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-51.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-281.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-168.17%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-140.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-122.20%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-131.06%
CURRENT VS TTM AVG
+50.19%
CURRENT VS 3Y AVG
+90.94%
CURRENT VS 5Y AVG
+84.87%
CURRENT VS 10Y AVG
+81.87%
CURRENT VS 15Y AVG
+79.17%
CURRENT VS 20Y AVG
+80.58%
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+28.64%
vs the sector median at left
SELLAS Life Sciences Group, Inc.
Market Cap
$2.11B
Return on Invested Capital (ROIC)
-25.45%
TTM Avg
-51.09%
3Y Avg
-281.01%
5Y Avg
-168.17%
Market Cap
$2.11B
Return on Invested Capital (ROIC)
-85.78%
TTM Avg
-36.41%
3Y Avg
-56.32%
5Y Avg
-60.45%
Market Cap
$2.11B
Return on Invested Capital (ROIC)
8.61%
TTM Avg
7.04%
3Y Avg
7.13%
5Y Avg
6.52%
Market Cap
$2.13B
Return on Invested Capital (ROIC)
-14.69%
TTM Avg
-4.44%
3Y Avg
-55.28%
5Y Avg
-75.35%
Market Cap
$2.08B
Return on Invested Capital (ROIC)
3.61%
TTM Avg
5.05%
3Y Avg
-22.39%
5Y Avg
-28.34%
Market Cap
$2.06B
Return on Invested Capital (ROIC)
-39.18%
TTM Avg
-43.45%
3Y Avg
-43.80%
5Y Avg
-51.45%
Market Cap
$2.06B
Return on Invested Capital (ROIC)
-45.19%
TTM Avg
-39.97%
3Y Avg
-37.50%
5Y Avg
-32.54%
Market Cap
$2.17B
Return on Invested Capital (ROIC)
16.96%
TTM Avg
-12.78%
3Y Avg
-0.83%
5Y Avg
5.59%
Market Cap
$2.05B
Return on Invested Capital (ROIC)
3.79%
TTM Avg
1.74%
3Y Avg
-1.46%
5Y Avg
-1.37%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | $2.11B | -25.45% | -51.09% | -281.01% | -168.17% |
| Vera Therapeutics, Inc. (VERA)vs › | $2.11B | -85.78% | -36.41% | -56.32% | -60.45% |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 8.61% | 7.04% | 7.13% | 6.52% |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | -14.69% | -4.44% | -55.28% | -75.35% |
| Alvotech (ALVO)vs › | $2.08B | 3.61% | 5.05% | -22.39% | -28.34% |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | -39.18% | -43.45% | -43.80% | -51.45% |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | -45.19% | -39.97% | -37.50% | -32.54% |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | 16.96% | -12.78% | -0.83% | 5.59% |
| Vericel Corporation (VCEL)vs › | $2.05B | 3.79% | 1.74% | -1.46% | -1.37% |
| Pharvaris N.V. (PHVS)vs › | $2.17B | -61.74% | -58.38% | -49.99% | -42.69% |
ROIC
-25.4%
ROE
-23.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -25.45% |
| 2026-03-31 | -29.06% |
| 2025-12-31 | -39.34% |
| 2025-09-30 | -58.27% |
| 2025-06-30 | -103.33% |
| 2025-03-31 | -99.51% |
| 2024-12-31 | -317.61% |
| 2024-09-30 | -206.22% |
| 2024-06-30 | -1132.21% |
| 2024-03-31 | -362.44% |
| 2023-06-30 | -717.65% |
| 2023-03-31 | -268.49% |
| 2022-12-31 | -588.61% |
| 2022-09-30 | -211.35% |
| 2022-06-30 | -141.10% |
| 2022-03-31 | -223.93% |
| 2021-12-31 | -90.53% |
| 2021-09-30 | -54.65% |
| 2021-06-30 | -38.97% |
| 2021-03-31 | -43.82% |
| 2020-12-31 | -50.37% |
| 2020-09-30 | -229.98% |
| 2020-06-30 | -319.52% |
| 2020-03-31 | -241.27% |
| 2019-12-31 | -288.04% |
| 2019-09-30 | -118.51% |
| 2019-06-30 | -105.46% |
| 2019-03-31 | -254.17% |
| 2018-12-31 | -224.05% |
| 2018-09-30 | -100.94% |
| 2018-06-30 | -168.14% |
| 2018-03-31 | -148.92% |
| 2017-12-31 | -132.73% |
| 2017-09-30 | -63.90% |
| 2017-06-30 | -55.37% |
| 2017-03-31 | -54.09% |
| 2016-12-31 | -57.40% |
| 2016-09-30 | -56.50% |
| 2016-06-30 | -70.05% |
| 2016-03-31 | -130.39% |
| 2015-12-31 | -128.70% |
| 2015-09-30 | -84.08% |
| 2015-06-30 | -68.20% |
| 2015-03-31 | -65.21% |
| 2014-12-31 | -91.23% |
| 2014-09-30 | -102.02% |
| 2014-06-30 | -92.02% |
| 2014-03-31 | -57.00% |
| 2013-12-31 | -122.26% |
| 2013-09-30 | -48.37% |
| 2013-06-30 | -70.32% |
| 2013-03-31 | -66.72% |
| 2012-12-31 | -54.26% |
| 2012-09-30 | -85.26% |
| 2012-06-30 | -65.25% |
| 2011-12-31 | -82.89% |
| 2011-09-30 | -156.75% |
| 2011-06-30 | -96.36% |
| 2011-03-31 | -534.44% |
| 2010-12-31 | -678.57% |
| 2010-09-30 | -546.89% |
| 2010-06-30 | -285.58% |
| 2010-03-31 | -270.01% |
| 2009-12-31 | -2383.01% |
| 2009-09-30 | -296.58% |
| 2009-06-30 | -517.63% |
| 2009-03-31 | -247.43% |
| 2008-12-31 | -161.90% |
| 2008-09-30 | -108.74% |
| 2008-06-30 | -88.52% |
| 2008-03-31 | -150.32% |
| 2007-12-31 | -110.28% |
| 2007-09-30 | -78.54% |
